, Abstract-Background: Prescription opioid abuse and overdose has steadily increased in the United States (US) over the past two decades, and current research has shown a dramatic increase in hospitalizations resulting from opioid poisonings. Still, much is unknown about the clinical and demographic features of patients presenting to emergency departments (EDs) for poisoning from prescription drugs. Objective: We sought to evaluate ED visits by adults for prescription opioids. Methods: This was a retrospective cohort study utilizing 2006-2011 data from the Nationwide Emergency Department Sample. Total number of admissions (weighted), disposition, gender, age, expected payer, income, geographic region, charges, and procedures performed were examined. Results: From 2006 through 2010, there were 259,093 ED visits by adults for poisoning by opioids, and 53.50% of these were unintentional. The overall mean age of patients was 45.5 years, with more visits made by females (52.37%). Patients who unintentionally overdosed were more likely to have Medicare (36.54%), whereas those who intentionally overdosed had private insurance (29.41%). The majority of patients resided in the South (40.93%) and came from lower-income neighborhoods. Approximately 108,504 patients were discharged, and 140,395 were admitted. Conclusions: There were over 250,000 visits to US EDs from 2006 through 2011 with a primary diagnosis of poisoning by a prescription opioid. Females made the majority of visits, and over half were admitted to the hospital, resulting in over $4 billion in charges. Future studies should examine preventative measures, optimal screening, and intervention programs for these patients. Ó 2015 Elsevier Inc.
INTRODUCTION
Opioid abuse and overdose has steadily increased in the United States for over two decades. Opioid overdoserelated deaths have quadrupled between 1990 and 2010, and it is estimated that roughly 100 people die each day from opioid-related overdoses (1) (2) (3) . Unintentional poisoning now represents the leading cause of injury death in the United States for adults ages 25-64 years (4, 5) . Of unintentional poisonings, the vast majority are related to prescription and illicit opioid overdoses (2, 3, 6) . In particular, prescription opioid medications seem to confer a major risk to those affected by opioid dependency. These prescriptions, which are often written legitimately for pain control, may be stolen by family members, sold on the street, or taken in excess quantities by the patient themselves (2) .
In the mid-1990s, the American Pain Society and the American Academy of Anesthesiologists developed Because information contained in the s Emergency Department Sample is de-identified and considered not human subjects research, approval from the West Virginia University Institutional Review Board was not required for this study. This work was published as an abstract in the Annals of Emergency Medicine in 2012.
position statements supporting increased use of opioids to treat pain, and laws were enacted to protect physicians prescribing such medications. A general movement toward adequate and appropriate pain control management for patients occurred when the Joint Commission created pain management standards in 2001 (7) . After these policies went into effect, there was a 300% increase in the sale of prescription opioids in the United States (US), with enough prescription painkillers to medicate every American adult for 1 month in 2010 (2) .
Although prescribed painkillers are intended for treatment and pain control, the repercussions of the aforementioned policies and position statements have been shown to be associated with increased opioid medication addiction, abuse, and unintentional poisoning (5, (8) (9) (10) . In 2010, the National Institute of Drug Abuse revealed that approximately seven million Americans reported prescription drug abuse within 30 days, with opioids outranking stimulants and sedatives by five-and twofold, respectively (11, 12) .
A recent paper by Coben et al. showed a dramatic increase in hospitalizations resulting from poisoning by prescription opioids, sedatives, and tranquilizers between 1999 and 2006 (3). However, less information exists about emergency department (ED) visits for poisonings from these substances. Further insight into the unique features of this population may shed light on which populations are most at risk for opioid abuse and provide critical information about the magnitude of the problem. The objective of the current study was to examine the number of ED visits related to poisoning by prescription opioids and describe the sociodemographic and clinical features of this population.
METHODS
This was a retrospective cohort study using 5 years of data (2006) (2007) (2008) (2009) (2010) (2011) from the Nationwide Emergency Department Sample (NEDS)-a database that is part of the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project (HCUP) (13) . The NEDS is a 20% stratified, multistage sample designed to represent national estimates of US ED visits each year. It contains over 26 million records from ED visits from 950 hospitals in the United States and is the largest US all-payer ED database (13) . Hospital-based EDs that are selected to contribute data to the NEDS are determined by HCUP to represent all of the United States (13) . The NEDS current study was deemed ''not human subjects research'' by our institutions' institutional review board because information contained in the NEDS is de-identified.
The following International Classification of Diseases, 9 th Revision, Clinical Modification (ICD-9-CM) codes for prescription opioids were included: 965.02 (methadone); 965.09 (other narcotics including codeine, meperidine, morphine). These ICD-9-CM codes cover poisoning by prescription opioid medications and do not include heroin. Intentionality was determined by the presence of an External Cause of Injury Code (e-code) in the E850-E858 range (accidental poisonings by drugs, medicinal substances, and biologicals). These cases represent ED visits where prescription drug poisoning was listed as the primary diagnosis.
We also examined the number of admissions, disposition, gender, age, expected payer, income, geographic region, mean and total charges, and procedures performed. SAS-Callable SUDAAN software (RTI International, Research Triangle Park, NC) was used to create unbiased standard errors and to produce weighted estimates. Differences were considered statistically significant (p < 0.05) if confidence intervals did not overlap.
RESULTS

Demographics
From 2006-2011, there were an estimated 259,093 ED adult visits for poisoning by opioids, with 53.50% being unintentional. The number of ED visits by year is represented in Figure 1 , representing a steady increase annually. The mean age of the sample was 45.5 years (SE 0.12) ( Table 1) . On average, females were significantly older (47.6 years; 95% confidence interval [CI]: 47.3-47.9; SE 0.14 vs. 43.2 years; 42.9-43.5; SE 0.14) and accounted for more of the visits (52.36% vs. 47.63%) ( Table 1 ). The number of ED visits for opioid poisoning by patients in the 18-30-year age group was significantly higher than all other age categories (Table 2 ). Additionally, significantly more patients were admitted to the same hospital (54.19%). The lowest number of ED visits for opioid poisoning was from patients living in the highest quartile neighborhoods ($$63,000) (16.41%) and overall, significantly more visits were made by patients with Medicare (29.60%) ( Table 1 ). The majority of visits occurred in the South (40.93%), compared to all other regions. 
Intentionality
Poisonings were classified from these data as either ''unintentional,'' ''intentional,'' or ''undetermined.'' Of the 259,093 ED visits for poisonings between 2006 and 2011, 26.5% were intentional, whereas 53.50% were unintentional and 20.0% undetermined (Table 3) .
Significantly more females were classified as both unintentional (52.67%) and intentional (54.95%). When comparing payment source, Medicare was significantly higher for unintentional overdoses (36.41%) and private insurance was higher for intentional overdoses (29.29%). Additionally, the 4 th -quartile income level remained significantly lower and admission rates remained higher for both unintentional and intentional poisonings.
Age categories, ranging from 18 to 100 years, were compared with all three classifications of intentionality. Although unintentional poisonings were significantly higher in all age categories compared to intentional and undetermined, the number of these poisonings increased with age (Table 2) . Likewise, the total number of intentional poisonings decreased with increasing age.
Charges, Diagnoses, and Procedures
The average charge per visit was $3515.27 for those discharged and $27,491.87 for those admitted. The total charges over the entire 5-year period for visits resulting in discharge from the ED were $381,420,856.08, and $3,859,721,088.65 for admissions.
Poisoning by psychotropic agents or other medications and drugs, as well as substance-related disorders, were the top primary diagnoses of ED visits ( Table 4) . The top 10 primary procedures included an indwelling catheter, intubation, and head computed tomography scan (Table 4) .
DISCUSSION
Our data show more than 250,000 visits to US EDs between 2006 and 2011 for poisoning by prescribed opioids. A previous landmark study by Coben et al. using the Nationwide Inpatient Sample found a 65% increase in US hospitalizations for opioids as well as sedatives and tranquilizers between 1999 and 2006 (3). Similarly, our (14) . Therefore, even large, national databases may underestimate the vast magnitude of national prescription opioid abuse (14) . In 2008, approximately 20,044 deaths were attributed to prescription drug overdose, of which 14,800 (73.8%) resulted from prescribed opioids. This is far greater than the number of overdose deaths due to heroin and cocaine combined (14) . Between 1999 and 2008, overdose deaths from opioid pain medications increased almost fourfold (15) . Shockingly, Americans constitute only 4.6% of the world's overall population, but use 80% of the global opioid supply (16) . Opioid abuse in the United States represents a growing public health threat. Elevated prevalence and risk factors associated with opioid abuse have been observed in some socioeconomic groups, specifically low-income individuals and those living in rural areas of the United States (2) . Although studies evaluating demographics of this population may help in targeting certain at-risk groups, a more unified effort, including changing the paradigm of opioid prescribing, is necessary to fully address this nationwide problem (2) . For instance, it is possible that there were higher unintentional opioid poisonings among those who used Medicare, due to therapeutic misadventures as opposed to recreational abuse. Future programs may consider gender-specific interventions, as research has shown that women are more likely to be prescribed medications that have abuse potential and use such drugs for coping more so than men (17, 18) .
Analysis of large-scale databases has revealed the growing problem of prescription drug abuse in the United States. Our study adds additional information about the magnitude of this issue, as well as health care utilization patterns and exorbitant costs of this public health crisis. The Centers for Disease Control and Prevention currently recommends the development of state-wide electronic tracking systems to monitor distribution of prescription drugs in health care settings (2) . This may hold medical providers accountable for prescribing beyond the necessary treatment level (2) . Laws to prevent doctor shopping and drug diversion, coupled with better access to treatment resources for patients, are needed (2) . Furthermore, the increase in the number of opioid treatment centers provides an ideal opportunity to conduct qualitative research with recovering opioid users to provide insight into the factors contributing to the start of their addictions.
Limitations
Because the ED visit is the unit of analysis in the NEDS, as opposed to the individual patient, it is possible that patients were represented multiple times in our sample if they visited the hospital more than once for prescription overdose. Furthermore, the de-identified nature of the data precluded us from examining valuable information specific to the ED visit, such as provider notes and medications that the patients were currently prescribed. The reasons for unintentional visits were also unknown to us. For example, it was unclear from these data if an unintentional poisoning represented a recreational mishap or an oversedation from a prescribed pain medication, which may occur among cancer patients. This information would be valuable in further establishing a risk profile for patients who overdose from prescription drugs.
The classification of ''undetermined intentionality'' was assumed to be considered missing data or visits that were not coded as either ''unintentional'' or ''intentional.'' Outcomes of this study may have been different if there were fewer reports of undetermined classifications from the NEDS analysis. One of the limitations of using the NEDS database is that this is a retrospective study, and data were not originally collected for the purposes of this particular study, along with the possibility of miscoded data. Additionally, there is a possibility that the e-codes used were underutilized or incorrectly coded for these patients. This study considered only poisonings coded as being the first-listed diagnosis, so it is possible that these results may not reflect visits in which opioid poisonings were listed as secondary diagnosis (19) . Also, the estimated charge data may not equal the actual costs of these visits, as the NEDS provides only charge data (19) .
CONCLUSION
There were over 250,000 visits to EDs in the United States from 2006-2011 with a primary diagnosis of poisoning by a prescription opioid. The majority of the patients were female, and over half were admitted to the hospital. The charges for ED visits and subsequent hospitalizations totaled $4 billion during the 5-year period. One-half of cases were unintentional. This information can be used for focused behavioral and withdrawal support programs that may be gender-specific, along with targeted antidrug campaigns. Future studies should examine how to best prevent such poisonings and determine optimal screening and intervention programs for these patients. Likewise, further research is suggested for physician opioid-prescribing patterns, opioid abuse risk factors beyond general demographics, and interventions for those already afflicted by opioid dependence.
